Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
NUVLNuvalent	$4.24bn	n/a	n/a
ALVOAlvotech SA	$4.20bn	n/a	n/a
MRTXMirati Therapeutics	$4.12bn	n/a	n/a
ALKSVAlkermes	$4.05bn	18.02	n/a
ALKSAlkermes	$3.96bn	6.64	n/a
RYZBRayzebio	$3.81bn	n/a	n/a
CBAYCymaBay Therapeutics	$3.73bn	n/a	n/a
IMVTImmunovant	$3.71bn	n/a	n/a
MRUSMerus NV	$3.59bn	n/a	n/a
CRNXCrinetics Pharmaceuticals	$3.50bn	n/a	n/a
RAREUltragenyx Pharmaceutical	$3.34bn	n/a	n/a
GHGuardant Health	$3.32bn	n/a	n/a
DYNDyne Therapeutics	$3.11bn	n/a	n/a
BHVNBiohaven	$3.10bn	n/a	n/a
SWTXSpringWorks Therapeutics	$3.07bn	n/a	n/a
FOLDAmicus Therapeutics	$2.90bn	n/a	n/a
KDNYChinook Therapeutics	$2.90bn	n/a	n/a
XENEXenon Pharmaceuticals	$2.87bn	n/a	n/a
ARWRArrowhead Pharmaceuticals	$2.85bn	n/a	n/a
PTCTPTC Therapeutics	$2.79bn	n/a	n/a